These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24768849)

  • 41. A multi-institutional experience with robotic-assisted radical hysterectomy for early stage cervical cancer.
    Lowe MP; Chamberlain DH; Kamelle SA; Johnson PR; Tillmanns TD
    Gynecol Oncol; 2009 May; 113(2):191-4. PubMed ID: 19249082
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Radical hysterectomy with pelvic lymphadenectomy in patients with carcinoma of the uterine cervix--3 years' experience].
    Bosković V; Glisić A; Petković S
    Srp Arh Celok Lek; 1998; 126(5-6):183-7. PubMed ID: 9863378
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcome in early cervical cancer following pre-operative low dose rate brachytherapy: a ten-year follow up of 257 patients treated at a single institution.
    Ngô C; Alran S; Plancher C; Fourchotte V; Petrow P; Campitelli M; Batwa S; Sastre X; Salmon RJ; de la Rochefordière A;
    Gynecol Oncol; 2011 Nov; 123(2):248-52. PubMed ID: 21906789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estimation of tumor volume in cervical cancer by magnetic resonance imaging.
    Narayan K; McKenzie A; Fisher R; Susil B; Jobling T; Bernshaw D
    Am J Clin Oncol; 2003 Oct; 26(5):e163-8. PubMed ID: 14528092
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primary uterine cervical cancer: correlation of preoperative magnetic resonance imaging and clinical staging (FIGO) with histopathology findings.
    Kraljević Z; Visković K; Ledinsky M; Zadravec D; Grbavac I; Bilandzija M; Soljacić-Vranes H; Kuna K; Klasnić K; Krolo I
    Coll Antropol; 2013 Jun; 37(2):561-8. PubMed ID: 23941005
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-IB1-2 cervical carcinoma.
    Grisaru DA; Covens A; Franssen E; Chapman W; Shaw P; Colgan T; Murphy J; DePetrillo D; Lickrish G; Laframboise S; Rosen B
    Cancer; 2003 Apr; 97(8):1904-8. PubMed ID: 12673716
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DVH parameters and outcome for patients with early-stage cervical cancer treated with preoperative MRI-based low dose rate brachytherapy followed by surgery.
    Haie-Meder C; Chargari C; Rey A; Dumas I; Morice P; Magné N
    Radiother Oncol; 2009 Nov; 93(2):316-21. PubMed ID: 19586673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Laparoscopic radical hysterectomy after initial brachytherapy for stage IB1 cervical cancer: feasibility and results].
    Uzan C; Nikpayam M; Merlot B; Gouy S; Belghiti J; Haie-Meder C; Nickers P; Narducci F; Morice P; Leblanc E
    Gynecol Obstet Fertil; 2013 Oct; 41(10):571-7. PubMed ID: 24139815
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
    Monk BJ; Cha DS; Walker JL; Burger RA; Ramsinghani NS; Manetta A; DiSaia PJ; Berman ML
    Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does a uterine manipulator affect cervical cancer pathology or identification of lymphovascular space involvement?
    Rakowski JA; Tran TA; Ahmad S; James JA; Brudie LA; Pernicone PJ; Radi MJ; Holloway RW
    Gynecol Oncol; 2012 Oct; 127(1):98-101. PubMed ID: 22800652
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Can parametrectomy be avoided in early cervical cancer? An algorithm for the identification of patients at low risk for parametrial involvement.
    Gemer O; Eitan R; Gdalevich M; Mamanov A; Piura B; Rabinovich A; Levavi H; Saar-Ryss B; Halperin R; Finci S; Beller U; Bruchim I; Levy T; Ben Shachar I; Ben Arie A; Lavie O
    Eur J Surg Oncol; 2013 Jan; 39(1):76-80. PubMed ID: 23131429
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Matched-case comparison for the role of surgery in FIGO stage Ib1-IIa squamous cell carcinoma of cervix and suspicious para-aortic lymph node metastasis.
    Kim HS; Park NH; Wu HG; Cho JY; Chung HH; Kim JW; Song YS; Kim SH; Kang SB
    Ann Surg Oncol; 2009 Jan; 16(1):133-9. PubMed ID: 18979134
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Less radical surgery than radical hysterectomy in early stage cervical cancer: a pilot study.
    Pluta M; Rob L; Charvat M; Chmel R; Halaska M; Skapa P; Robova H
    Gynecol Oncol; 2009 May; 113(2):181-4. PubMed ID: 19264352
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical staging and histopathological findings after radical hysterectomy in FIGO stage IIB cervical cancer.
    Mandic A; Novakovic P; Mihajlovic O; Stojiljkovic B; Rajovic J; Davidovic M
    J BUON; 2008; 13(1):51-4. PubMed ID: 18404786
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of a low-risk subset of patients with stage IB invasive squamous cancer of the cervix possibly suited to less radical surgical treatment.
    Kinney WK; Hodge DO; Egorshin EV; Ballard DJ; Podratz KC
    Gynecol Oncol; 1995 Apr; 57(1):3-6. PubMed ID: 7705699
    [TBL] [Abstract][Full Text] [Related]  

  • 56. What is the risk for parametrial involvement in women with early-stage cervical cancer with tumour <20 mm and with negative sentinel lymph nodes?
    Klat J; Sevcik L; Simetka O; Graf P; Dvorackova J; Kraft O
    Aust N Z J Obstet Gynaecol; 2012 Dec; 52(6):540-4. PubMed ID: 23216324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Survival outcomes of laparoscopic versus open radical hysterectomy in early cervical cancer with incidentally identified high-risk factors.
    Kim NR; Kim SI; Suh DH; Kim HS; Kim K; Chung HH; No JH; Kim YB; Kim JW; Park NH; Song YS; Choi CH; Lee M
    Gynecol Oncol; 2023 Jul; 174():224-230. PubMed ID: 37229880
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The incidence of parametrial tumor involvement in select patients with early cervix cancer is too low to justify parametrectomy.
    Stegeman M; Louwen M; van der Velden J; ten Kate FJ; den Bakker MA; Burger CW; Ansink AC
    Gynecol Oncol; 2007 May; 105(2):475-80. PubMed ID: 17292460
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Can preoperative MRI accurately evaluate nodal and parametrial invasion in early stage cervical cancer?
    Chung HH; Kang SB; Cho JY; Kim JW; Park NH; Song YS; Kim SH; Lee HP
    Jpn J Clin Oncol; 2007 May; 37(5):370-5. PubMed ID: 17556538
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of criteria for ovarian preservation in cervical cancer patients treated with radical surgery with or without neoadjuvant chemotherapy: a multicenter retrospective study and meta-analysis.
    Hu T; Wu L; Xing H; Yang R; Li X; Huang K; Jia Y; Zhang Q; Chen Z; Wang S; Liu D; Han X; Lin Z; Qu P; Cai H; Song X; Tian X; Wang H; Wang S; Xie X; Li S; Ma D
    Ann Surg Oncol; 2013 Mar; 20(3):881-90. PubMed ID: 23054110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.